cache/6a886343334ff8170eab961d21399a89290de2e67490c8cf73e1e0a449fac513

IT:3DNASRL

3DnA

  • Privately Held

Company Overview

Metric
Company Name3Altair Engineering Inc.Code Bio
SymbolALTR
MSH IDIT:3DNASRLCOM:ALTAIRCOM:CODEBIOTX
MarketPRIVATESTOCKSPRIVATE
SectorTechnologyTechnologyHealthcare & Health Services
IndustryAdditive ManufacturingSoftware - InfrastructureBiotechnology
CountryITUSUS
Stage
Employee Count3.40K37
Website3dnasrl.italtair.comcodebiotx.com
LinkedIncode-biotherapeutics
Founders

Market Metrics

Metric
Market Cap8.19B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue612.70M
Revenue (LTM)
Revenue (NTM)
Gross Profit490.91M
EBITDA56.22M
Operating Income243K
Net Income-8.93M
EPS-0.11
Diluted EPS-0.11
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.81
Operating Profit Margin0.03
EBITDA Margin0.09
Net Profit Margin0.04
Return on Equity0.04
Return on Assets0.02
Return on Capital Employed0.02

Valuation Multiples

Metric
P/E Ratio-422.92
P/B Ratio11.03
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio13.43
EV Multiple137.96

Operational Metrics

Metric
Days Sales Outstanding81.45
Days Payables Outstanding14.89
Days Inventory Outstanding0.00
Operating Cycle123.38
Cash Conversion Cycle96.42
Asset Turnover0.47

Cash Flow Metrics

Metric
Operating Cash Flow127.31M
Free Cash Flow117.11M
Cash Flow to Debt0.60
Operating Cash Flow/Sales0.23
Free Cash Flow Yield0.02

Balance Sheet Metrics

Metric
Cash & Equivalents467.46M
Accounts Receivable-19.14M
Inventory
Goodwill458.13M
Debt to Capitalization0.32
Debt to Assets0.27
Current Ratio1.99
Quick Ratio3.11

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.15
R&D to Revenue0.35
SG&A to Revenue0.14